{"transactions":[{"id":741779,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T20:15:19.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 9, 2026 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":30000,"derivative":{"exercise_price":10.55,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001559570-26-000008","document":"form4-06112026_040613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000155957026000008/form4-06112026_040613.xml","form_type":"4"}},{"id":822947,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-04-01T20:17:20.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal monthly installments over 12 months following March 31, 2026."}],"balance_after":7500,"derivative":{"exercise_price":10.64,"expiration_date":"2036-03-30","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001559570-26-000006","document":"form4-04012026_080415.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000155957026000006/form4-04012026_080415.xml","form_type":"4"}},{"id":822946,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-04-01T20:17:20.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over 36 months following March 31, 2026."}],"balance_after":60000,"derivative":{"exercise_price":10.64,"expiration_date":"2036-03-30","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001559570-26-000006","document":"form4-04012026_080415.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000155957026000006/form4-04012026_080415.xml","form_type":"4"}},{"id":1104642,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-20T11:00:09.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 18, 2025, the date of the Issuer's 2025 Annual Meeting of Stockholders, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date."}],"balance_after":720,"derivative":{"exercise_price":3.22,"expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":720},"source":{"system":"sec-edgar","filing":"0000950170-25-088165","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559570/000095017025088165/ownership.xml","form_type":"4"}},{"id":1471746,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T20:00:04.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 20, 2024, the date of the Issuer's 2024 Annual Meeting of Stockholders, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date."}],"balance_after":18000,"derivative":{"exercise_price":0.49,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0000950170-24-076183","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559570/000095017024076183/ownership.xml","form_type":"4"}},{"id":1853906,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T20:00:19.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 14, 2023, the date of the Issuer's 2023 Annual Meeting of Stockholders, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date."}],"balance_after":18000,"derivative":{"exercise_price":2.12,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-23-037288","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559570/000120919123037288/doc4.xml","form_type":"4"}},{"id":2231119,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-15T20:00:27.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 14, 2022, the date of the Issuer's 2022 Annual Meeting of Stockholder, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date."}],"balance_after":18000,"derivative":{"exercise_price":1.98,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-22-036935","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559570/000120919122036935/doc4.xml","form_type":"4"}},{"id":3419564,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-09T23:01:56.000Z","date":"2019-09-05","kind":"grant","acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents an automatic annual award granted pursuant to the Issuer's non-employee director compensation plan.  The option shares vest and become exercisable in full on the earlier of (i) September 5, 2020 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting."}],"balance_after":52000,"derivative":{"exercise_price":0.266,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001209191-19-048964","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919119048964/doc4.xml","form_type":"4"}},{"id":3539614,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-05-03T19:00:23.000Z","date":"2019-05-01","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable."}],"balance_after":9031,"derivative":{"exercise_price":31.9,"expiration_date":"2023-05-07","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001144204-19-023712","document":"tv520407_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419023712/tv520407_4.xml","form_type":"4"}},{"id":3539613,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-03T19:00:23.000Z","date":"2019-05-01","kind":"sale","acquired":false,"shares":2000,"price":86.28,"value":172560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":39499,"source":{"system":"sec-edgar","filing":"0001144204-19-023712","document":"tv520407_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419023712/tv520407_4.xml","form_type":"4"}},{"id":3539612,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-03T19:00:23.000Z","date":"2019-05-01","kind":"exercise","acquired":true,"shares":2000,"price":31.9,"value":63800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":41499,"source":{"system":"sec-edgar","filing":"0001144204-19-023712","document":"tv520407_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419023712/tv520407_4.xml","form_type":"4"}},{"id":3554980,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-04-16T19:01:00.000Z","date":"2019-04-15","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable."}],"balance_after":11031,"derivative":{"exercise_price":31.9,"expiration_date":"2023-05-07","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001144204-19-019949","document":"tv519004_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419019949/tv519004_form4.xml","form_type":"4"}},{"id":3554979,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-16T19:01:00.000Z","date":"2019-04-15","kind":"sale","acquired":false,"shares":2000,"price":95,"value":190000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":39499,"source":{"system":"sec-edgar","filing":"0001144204-19-019949","document":"tv519004_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419019949/tv519004_form4.xml","form_type":"4"}},{"id":3554978,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-16T19:01:00.000Z","date":"2019-04-15","kind":"exercise","acquired":true,"shares":2000,"price":31.9,"value":63800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":41499,"source":{"system":"sec-edgar","filing":"0001144204-19-019949","document":"tv519004_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419019949/tv519004_form4.xml","form_type":"4"}},{"id":3564263,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-03T19:00:25.000Z","date":"2019-04-03","kind":"sale","acquired":false,"shares":562,"price":115.01,"value":64635.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":39499,"source":{"system":"sec-edgar","filing":"0001144204-19-018081","document":"tv517927_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419018081/tv517927_4.xml","form_type":"4"}},{"id":3564262,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-03T19:00:25.000Z","date":"2019-04-01","kind":"tax_withholding","acquired":false,"shares":482,"price":111.5,"value":53743.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person."}],"balance_after":40061,"source":{"system":"sec-edgar","filing":"0001144204-19-018081","document":"tv517927_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419018081/tv517927_4.xml","form_type":"4"}},{"id":3622946,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-03-01T19:00:25.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable."}],"balance_after":13031,"derivative":{"exercise_price":31.9,"expiration_date":"2023-05-07","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001144204-19-011719","document":"tv515268_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419011719/tv515268_4.xml","form_type":"4"}},{"id":3622945,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-01T19:00:25.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":2000,"price":103.16,"value":206320.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":40543,"source":{"system":"sec-edgar","filing":"0001144204-19-011719","document":"tv515268_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419011719/tv515268_4.xml","form_type":"4"}},{"id":3622944,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-01T19:00:25.000Z","date":"2019-03-01","kind":"exercise","acquired":true,"shares":2000,"price":31.9,"value":63800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":42543,"source":{"system":"sec-edgar","filing":"0001144204-19-011719","document":"tv515268_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419011719/tv515268_4.xml","form_type":"4"}},{"id":3645351,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-02-20T21:01:02.000Z","date":"2019-02-15","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable."}],"balance_after":15031,"derivative":{"exercise_price":31.9,"expiration_date":"2023-05-07","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001144204-19-009186","document":"tv514063_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419009186/tv514063_form4.xml","form_type":"4"}},{"id":3645350,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-20T21:01:02.000Z","date":"2019-02-15","kind":"sale","acquired":false,"shares":2000,"price":111.51,"value":223020.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":40543,"source":{"system":"sec-edgar","filing":"0001144204-19-009186","document":"tv514063_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419009186/tv514063_form4.xml","form_type":"4"}},{"id":3645349,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-20T21:01:02.000Z","date":"2019-02-15","kind":"exercise","acquired":true,"shares":2000,"price":31.9,"value":63800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":42543,"source":{"system":"sec-edgar","filing":"0001144204-19-009186","document":"tv514063_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419009186/tv514063_form4.xml","form_type":"4"}},{"id":3691646,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-01-18T19:04:17.000Z","date":"2019-01-16","kind":"grant","acquired":true,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2019."}],"balance_after":5300,"derivative":{"exercise_price":110.8,"expiration_date":"2029-01-16","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001144204-19-002142","document":"tv511183_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419002142/tv511183_4.xml","form_type":"4"}},{"id":3691645,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-18T19:04:17.000Z","date":"2019-01-16","kind":"grant","acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2019."}],"balance_after":40543,"source":{"system":"sec-edgar","filing":"0001144204-19-002142","document":"tv511183_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419002142/tv511183_4.xml","form_type":"4"}},{"id":3703591,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-04T19:01:13.000Z","date":"2019-01-04","kind":"sale","acquired":false,"shares":474,"price":97.48,"value":46205.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":37243,"source":{"system":"sec-edgar","filing":"0001144204-19-000723","document":"tv510395_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419000723/tv510395_form4.xml","form_type":"4"}},{"id":3708154,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-01-03T19:04:00.000Z","date":"2019-01-02","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":17031,"derivative":{"exercise_price":31.9,"expiration_date":"2023-05-07","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001144204-19-000502","document":"tv510193_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419000502/tv510193_form4.xml","form_type":"4"}},{"id":3708153,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-03T19:04:00.000Z","date":"2019-01-03","kind":"sale","acquired":false,"shares":699,"price":97.45,"value":68117.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":37717,"source":{"system":"sec-edgar","filing":"0001144204-19-000502","document":"tv510193_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419000502/tv510193_form4.xml","form_type":"4"}},{"id":3708152,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-03T19:04:00.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":2000,"price":98.28,"value":196560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":38416,"source":{"system":"sec-edgar","filing":"0001144204-19-000502","document":"tv510193_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419000502/tv510193_form4.xml","form_type":"4"}},{"id":3708151,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-03T19:04:00.000Z","date":"2019-01-02","kind":"exercise","acquired":true,"shares":2000,"price":31.9,"value":63800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":40416,"source":{"system":"sec-edgar","filing":"0001144204-19-000502","document":"tv510193_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419000502/tv510193_form4.xml","form_type":"4"}},{"id":3708150,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-03T19:04:00.000Z","date":"2019-01-01","kind":"tax_withholding","acquired":false,"shares":736,"price":100.79,"value":74181.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock and restricted stock units."}],"balance_after":38416,"source":{"system":"sec-edgar","filing":"0001144204-19-000502","document":"tv510193_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419000502/tv510193_form4.xml","form_type":"4"}},{"id":3724554,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2018-12-19T19:00:25.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable."}],"balance_after":19031,"derivative":{"exercise_price":31.9,"expiration_date":"2023-05-07","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001144204-18-065469","document":"tv509353_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418065469/tv509353_4.xml","form_type":"4"}},{"id":3724553,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-19T19:00:25.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":2000,"price":106.62,"value":213240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":39152,"source":{"system":"sec-edgar","filing":"0001144204-18-065469","document":"tv509353_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418065469/tv509353_4.xml","form_type":"4"}},{"id":3724552,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-19T19:00:25.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":2000,"price":31.9,"value":63800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":41152,"source":{"system":"sec-edgar","filing":"0001144204-18-065469","document":"tv509353_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418065469/tv509353_4.xml","form_type":"4"}},{"id":3741413,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-06T21:34:06.000Z","date":"2018-12-04","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares vest and become exercisable in full on the earlier of (i) December 4, 2019 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting."}],"balance_after":30000,"derivative":{"exercise_price":1.01,"expiration_date":"2028-12-04","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-18-061278","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919118061278/doc4.xml","form_type":"4"}},{"id":3741412,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-06T21:34:06.000Z","date":"2018-12-04","kind":"grant","acquired":true,"shares":46500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest and become exercisable over 12 equal quarterly installments measured from December 4, 2018."}],"balance_after":46500,"derivative":{"exercise_price":1.01,"expiration_date":"2028-12-04","underlying":"Common Stock","underlying_shares":46500},"source":{"system":"sec-edgar","filing":"0001209191-18-061278","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919118061278/doc4.xml","form_type":"4"}},{"id":3775608,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2018-11-02T19:01:47.000Z","date":"2018-11-01","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable."}],"balance_after":361,"derivative":{"exercise_price":21.5,"expiration_date":"2022-11-16","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001144204-18-057130","document":"tv506094_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418057130/tv506094_4.xml","form_type":"4"}},{"id":3775607,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-11-02T19:01:47.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":2000,"price":96.32,"value":192640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":39152,"source":{"system":"sec-edgar","filing":"0001144204-18-057130","document":"tv506094_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418057130/tv506094_4.xml","form_type":"4"}},{"id":3775606,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-11-02T19:01:47.000Z","date":"2018-11-01","kind":"exercise","acquired":true,"shares":2000,"price":21.5,"value":43000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":41152,"source":{"system":"sec-edgar","filing":"0001144204-18-057130","document":"tv506094_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418057130/tv506094_4.xml","form_type":"4"}},{"id":3789742,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2018-10-16T19:00:07.000Z","date":"2018-10-15","kind":"exercise","acquired":false,"shares":3425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable."}],"balance_after":2361,"derivative":{"exercise_price":21.5,"expiration_date":"2022-11-16","underlying":"Common Stock","underlying_shares":3425},"source":{"system":"sec-edgar","filing":"0001144204-18-054076","document":"tv504805_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418054076/tv504805_form4.xml","form_type":"4"}},{"id":3789741,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-10-16T19:00:07.000Z","date":"2018-10-15","kind":"sale","acquired":false,"shares":3425,"price":102.95,"value":352603.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":39152,"source":{"system":"sec-edgar","filing":"0001144204-18-054076","document":"tv504805_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418054076/tv504805_form4.xml","form_type":"4"}},{"id":3789740,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-10-16T19:00:07.000Z","date":"2018-10-15","kind":"exercise","acquired":true,"shares":3425,"price":21.5,"value":73637.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":42577,"source":{"system":"sec-edgar","filing":"0001144204-18-054076","document":"tv504805_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418054076/tv504805_form4.xml","form_type":"4"}},{"id":3795893,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-10-05T19:01:01.000Z","date":"2018-10-05","kind":"sale","acquired":false,"shares":759,"price":110.65,"value":83983.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":39152,"source":{"system":"sec-edgar","filing":"0001144204-18-052813","document":"tv504244_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418052813/tv504244_4.xml","form_type":"4"}},{"id":3798325,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-10-03T19:03:08.000Z","date":"2018-10-01","kind":"tax_withholding","acquired":false,"shares":426,"price":126.46,"value":53871.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the amount of securities beneficially owned following the reported transactions is provided as of the date of this Form 4."}],"balance_after":39911,"source":{"system":"sec-edgar","filing":"0001144204-18-052409","document":"tv503778_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418052409/tv503778_4.xml","form_type":"4"}},{"id":3798324,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-10-03T19:03:08.000Z","date":"2018-07-01","kind":"tax_withholding","acquired":false,"shares":416,"price":83.91,"value":34906.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the amount of securities beneficially owned following the reported transactions is provided as of the date of this Form 4."}],"balance_after":39911,"source":{"system":"sec-edgar","filing":"0001144204-18-052409","document":"tv503778_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418052409/tv503778_4.xml","form_type":"4"}},{"id":3798323,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-10-03T19:03:08.000Z","date":"2018-04-01","kind":"tax_withholding","acquired":false,"shares":423,"price":61.52,"value":26022.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the amount of securities beneficially owned following the reported transactions is provided as of the date of this Form 4."}],"balance_after":39911,"source":{"system":"sec-edgar","filing":"0001144204-18-052409","document":"tv503778_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418052409/tv503778_4.xml","form_type":"4"}},{"id":3798322,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-10-03T19:03:08.000Z","date":"2018-01-01","kind":"tax_withholding","acquired":false,"shares":1020,"price":58.42,"value":59588.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the amount of securities beneficially owned following the reported transactions is provided as of the date of this Form 4."}],"balance_after":39911,"source":{"system":"sec-edgar","filing":"0001144204-18-052409","document":"tv503778_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418052409/tv503778_4.xml","form_type":"4"}},{"id":3821810,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-07T18:00:44.000Z","date":"2018-09-05","kind":"sale","acquired":false,"shares":4917,"price":111.428,"value":547891.476,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.17 to $111.665, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":42196,"source":{"system":"sec-edgar","filing":"0001144204-18-048620","document":"tv502433_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418048620/tv502433_4.xml","form_type":"4"}},{"id":4039910,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2018-02-22T21:00:11.000Z","date":"2018-02-05","kind":"grant","acquired":true,"shares":4400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares of common stock underlying this option will vest on January 1, 2019, subject to the terms and conditions of the award and the 2012 Plan. The remainder of the shares of common stock underlying this option will vest pro rata on a monthly basis after the initial vesting date through January 1, 2022 (representing the vesting on each such vesting date of approximately 2.0833% of the shares of common stock initially underlying this option), subject to the terms and conditions of the award and the 2012 Plan."}],"balance_after":4400,"derivative":{"exercise_price":58.74,"expiration_date":"2028-02-05","underlying":"Common Stock","underlying_shares":4400},"source":{"system":"sec-edgar","filing":"0001144204-18-010356","document":"tv486819_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418010356/tv486819_4.xml","form_type":"4"}},{"id":4039909,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-22T21:00:11.000Z","date":"2018-02-05","kind":"grant","acquired":true,"shares":2900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying restricted stock units (\"RSUs\") granted on February 5, 2018, with each RSU representing the contingent right to receive one share of common stock upon vesting of the RSU. 25% of the shares of common stock underlying these RSUs will vest on January 1, 2019, subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan (the \"2012 Plan\"). The remainder of the shares of common stock underlying the RSUs will vest pro rata on every subsequent three-month anniversary of the initial vesting date through January 1, 2022 (representing the vesting on each such vesting date of 6.25% of the shares of common stock initially underlying these RSUs), subject to the terms and conditions of the award and the 2012 Plan."}],"balance_after":47113,"source":{"system":"sec-edgar","filing":"0001144204-18-010356","document":"tv486819_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418010356/tv486819_4.xml","form_type":"4"}},{"id":4191938,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-10-04T21:01:25.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":349,"price":58.8983,"value":20555.5067,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each employee of the Issuer who has received restricted stock awards has agreed to a mandatory sale of a sufficient number of shares of common stock to cover his or her withholding tax amounts upon the vesting of such restricted stock awards. The sales denoted here were made pursuant to such agreement to cover withholding tax obligations of the employee."}],"balance_after":44213,"source":{"system":"sec-edgar","filing":"0001144204-17-051414","document":"v476461_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417051414/v476461_4.xml","form_type":"4"}},{"id":4217701,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Option to Purchase Common Stock","published_at":"2017-09-05T21:00:31.000Z","date":"2017-09-01","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":21031,"derivative":{"exercise_price":31.9,"expiration_date":"2023-05-07","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001144204-17-046676","document":"v474655_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417046676/v474655_form4.xml","form_type":"4"}},{"id":4217700,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-09-05T21:00:31.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":1250,"price":117.43,"value":146787.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."}],"balance_after":44562,"source":{"system":"sec-edgar","filing":"0001144204-17-046676","document":"v474655_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417046676/v474655_form4.xml","form_type":"4"}},{"id":4217699,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-09-05T21:00:31.000Z","date":"2017-09-01","kind":"exercise","acquired":true,"shares":1250,"price":31.9,"value":39875.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."}],"balance_after":45812,"source":{"system":"sec-edgar","filing":"0001144204-17-046676","document":"v474655_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417046676/v474655_form4.xml","form_type":"4"}},{"id":4245504,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Option to Purchase Common Stock","published_at":"2017-08-02T21:00:33.000Z","date":"2017-08-01","kind":"exercise","acquired":false,"shares":1118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":0,"derivative":{"exercise_price":8.6667,"expiration_date":"2021-10-13","underlying":"Common Stock","underlying_shares":1118},"source":{"system":"sec-edgar","filing":"0001144204-17-040073","document":"v472268_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417040073/v472268_form4.xml","form_type":"4"}},{"id":4245503,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-08-02T21:00:33.000Z","date":"2017-08-01","kind":"sale","acquired":false,"shares":1118,"price":119,"value":133042.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."}],"balance_after":44562,"source":{"system":"sec-edgar","filing":"0001144204-17-040073","document":"v472268_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417040073/v472268_form4.xml","form_type":"4"}},{"id":4245502,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-08-02T21:00:33.000Z","date":"2017-08-01","kind":"exercise","acquired":true,"shares":1118,"price":8.6667,"value":9689.3706,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."}],"balance_after":45680,"source":{"system":"sec-edgar","filing":"0001144204-17-040073","document":"v472268_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417040073/v472268_form4.xml","form_type":"4"}},{"id":4257631,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-07-13T21:00:20.000Z","date":"2017-07-11","kind":"sale","acquired":false,"shares":553,"price":124.01,"value":68577.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."}],"balance_after":44562,"source":{"system":"sec-edgar","filing":"0001144204-17-036753","document":"v470756_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417036753/v470756_4.xml","form_type":"4"}},{"id":4263791,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-07-05T21:01:46.000Z","date":"2017-07-03","kind":"sale","acquired":false,"shares":100,"price":121.35,"value":12135.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each employee of the Issuer who has received restricted stock awards has agreed to a mandatory sale of a sufficient number of shares of common stock to cover his or her withholding tax amounts upon the vesting of such restricted stock awards. The sales denoted here were made pursuant to such agreement to cover withholding tax obligations of the employee."}],"balance_after":45115,"source":{"system":"sec-edgar","filing":"0001144204-17-035812","document":"v470323_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417035812/v470323_form4.xml","form_type":"4"}},{"id":4263790,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-07-05T21:01:46.000Z","date":"2017-07-03","kind":"sale","acquired":false,"shares":250,"price":121.2,"value":30300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each employee of the Issuer who has received restricted stock awards has agreed to a mandatory sale of a sufficient number of shares of common stock to cover his or her withholding tax amounts upon the vesting of such restricted stock awards. The sales denoted here were made pursuant to such agreement to cover withholding tax obligations of the employee."}],"balance_after":45215,"source":{"system":"sec-edgar","filing":"0001144204-17-035812","document":"v470323_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417035812/v470323_form4.xml","form_type":"4"}},{"id":4334953,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Option to Purchase Common Stock","published_at":"2017-05-03T21:01:47.000Z","date":"2017-05-01","kind":"exercise","acquired":false,"shares":1117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":1118,"derivative":{"exercise_price":8.6667,"expiration_date":"2021-11-13","underlying":"Common Stock","underlying_shares":1117},"source":{"system":"sec-edgar","filing":"0001144204-17-024326","document":"v466056_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417024326/v466056_4.xml","form_type":"4"}},{"id":4334952,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-05-03T21:01:47.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":1117,"price":112.18,"value":125305.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."}],"balance_after":45465,"source":{"system":"sec-edgar","filing":"0001144204-17-024326","document":"v466056_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417024326/v466056_4.xml","form_type":"4"}},{"id":4334951,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-05-03T21:01:47.000Z","date":"2017-05-01","kind":"exercise","acquired":true,"shares":1117,"price":8.6667,"value":9680.7039,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."}],"balance_after":46582,"source":{"system":"sec-edgar","filing":"0001144204-17-024326","document":"v466056_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417024326/v466056_4.xml","form_type":"4"}},{"id":4354361,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-04-11T21:00:36.000Z","date":"2017-04-10","kind":"sale","acquired":false,"shares":558,"price":108.51,"value":60548.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."}],"balance_after":45465,"source":{"system":"sec-edgar","filing":"0001144204-17-020065","document":"v464077_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417020065/v464077_4.xml","form_type":"4"}},{"id":4357910,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-04-05T21:00:45.000Z","date":"2017-04-03","kind":"sale","acquired":false,"shares":346,"price":114.9973,"value":39789.0658,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each employee of the Issuer who has received restricted stock awards has agreed to a mandatory sale of a sufficient number of shares of common stock to cover his or her withholding tax amounts upon the vesting of such restricted stock awards. The sales denoted here were made pursuant to such agreement to cover withholding tax obligations of the employee."}],"balance_after":46023,"source":{"system":"sec-edgar","filing":"0001144204-17-019295","document":"v463647_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417019295/v463647_4.xml","form_type":"4"}},{"id":4403297,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Option to Purchase Common Stock","published_at":"2017-03-03T21:01:40.000Z","date":"2017-03-01","kind":"exercise","acquired":false,"shares":1350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":5786,"derivative":{"exercise_price":21.5,"expiration_date":"2022-11-16","underlying":"Common Stock","underlying_shares":1350},"source":{"system":"sec-edgar","filing":"0001144204-17-012809","document":"v461097_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417012809/v461097_4.xml","form_type":"4"}},{"id":4403296,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-03-03T21:01:40.000Z","date":"2017-03-01","kind":"sale","acquired":false,"shares":1350,"price":128.66,"value":173691.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."}],"balance_after":46369,"source":{"system":"sec-edgar","filing":"0001144204-17-012809","document":"v461097_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417012809/v461097_4.xml","form_type":"4"}},{"id":4403295,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-03-03T21:01:40.000Z","date":"2017-03-01","kind":"exercise","acquired":true,"shares":1350,"price":21.5,"value":29025.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."}],"balance_after":47719,"source":{"system":"sec-edgar","filing":"0001144204-17-012809","document":"v461097_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417012809/v461097_4.xml","form_type":"4"}},{"id":4468259,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Option to Purchase Common Stock","published_at":"2017-02-03T21:00:49.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares of common stock underlying this option will vest on January 1, 2018, subject to the terms and conditions of the award and the 2012 Plan. The remainder of the shares of common stock underlying this option will vest pro rata on a monthly basis after the initial vesting date through January 1, 2021 (representing the vesting on each such vesting date of approximately 2.0833% of the shares of common stock initially underlying this option), subject to the terms and conditions of the award and the 2012 Plan."}],"balance_after":10000,"derivative":{"exercise_price":107.18,"expiration_date":"2027-02-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001144204-17-006032","document":"v458366_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417006032/v458366_4.xml","form_type":"4"}},{"id":4468258,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-02-03T21:00:49.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"25% of the shares of restricted stock will vest on January 1, 2018, subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan (the \"2012 Plan\"). The remaining shares of restricted stock will vest pro rata on every subsequent three-month anniversary of the initial vesting date through January 1, 2021 (representing the vesting on each such vesting date of 6.25% of the shares of restricted stock), subject to the terms and conditions of the award and the 2012 Plan."}],"balance_after":46369,"source":{"system":"sec-edgar","filing":"0001144204-17-006032","document":"v458366_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417006032/v458366_4.xml","form_type":"4"}},{"id":4492976,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-01-11T21:00:42.000Z","date":"2017-01-09","kind":"sale","acquired":false,"shares":1565,"price":106.01,"value":165905.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."}],"balance_after":40369,"source":{"system":"sec-edgar","filing":"0001144204-17-001887","document":"v456743_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417001887/v456743_4.xml","form_type":"4"}},{"id":4498145,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2017-01-05T21:01:09.000Z","date":"2017-01-03","kind":"sale","acquired":false,"shares":988,"price":103.9191,"value":102672.0708,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each employee of the Issuer who has received restricted stock awards has agreed to a mandatory sale of a sufficient number of shares of common stock to cover his or her withholding tax amounts upon the vesting of such restricted stock awards. The sales denoted here were made pursuant to such agreement to cover withholding tax obligations of the employee."}],"balance_after":41934,"source":{"system":"sec-edgar","filing":"0001144204-17-000940","document":"v456335_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417000940/v456335_4.xml","form_type":"4"}},{"id":4531159,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2016-12-06T21:00:25.000Z","date":"2016-12-02","kind":"sale","acquired":false,"shares":1350,"price":99.75,"value":134662.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."}],"balance_after":42922,"source":{"system":"sec-edgar","filing":"0001144204-16-138201","document":"v454514_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420416138201/v454514_4.xml","form_type":"4"}},{"id":4580665,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2016-10-12T21:00:37.000Z","date":"2016-10-10","kind":"sale","acquired":false,"shares":411,"price":153.34,"value":63022.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."}],"balance_after":44272,"source":{"system":"sec-edgar","filing":"0001144204-16-127903","document":"v450475_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420416127903/v450475_4.xml","form_type":"4"}},{"id":4584131,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Option to Purchase Common Stock","published_at":"2016-10-05T21:06:33.000Z","date":"2016-10-03","kind":"exercise","acquired":false,"shares":1350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":8486,"derivative":{"exercise_price":21.5,"expiration_date":"2022-11-16","underlying":"Common Stock","underlying_shares":1350},"source":{"system":"sec-edgar","filing":"0001144204-16-127098","document":"v450070_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420416127098/v450070_4.xml","form_type":"4"}},{"id":4584130,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2016-10-05T21:06:33.000Z","date":"2016-10-03","kind":"sale","acquired":false,"shares":163,"price":163.1997,"value":26601.5511,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each employee of the Issuer who has received restricted stock awards has agreed to a mandatory sale of a sufficient number of shares of common stock to cover his or her withholding tax amounts upon the vesting of such restricted stock awards. The sales denoted here were made pursuant to such agreement to cover withholding tax obligations of the employee."}],"balance_after":44683,"source":{"system":"sec-edgar","filing":"0001144204-16-127098","document":"v450070_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420416127098/v450070_4.xml","form_type":"4"}},{"id":4584129,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2016-10-05T21:06:33.000Z","date":"2016-10-03","kind":"sale","acquired":false,"shares":1350,"price":163.06,"value":220131.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."}],"balance_after":44846,"source":{"system":"sec-edgar","filing":"0001144204-16-127098","document":"v450070_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420416127098/v450070_4.xml","form_type":"4"}},{"id":4584128,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2016-10-05T21:06:33.000Z","date":"2016-10-03","kind":"exercise","acquired":true,"shares":1350,"price":21.5,"value":29025.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."}],"balance_after":46196,"source":{"system":"sec-edgar","filing":"0001144204-16-127098","document":"v450070_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420416127098/v450070_4.xml","form_type":"4"}},{"id":4593181,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2016-09-28T21:00:19.000Z","date":"2016-09-26","kind":"sale","acquired":false,"shares":886,"price":166.03,"value":147102.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."}],"balance_after":44846,"source":{"system":"sec-edgar","filing":"0001144204-16-125866","document":"v449570_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420416125866/v449570_4.xml","form_type":"4"}},{"id":4593180,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and EVP - Development"}}],"security":"Common Stock","published_at":"2016-09-28T21:00:19.000Z","date":"2016-09-26","kind":"sale","acquired":false,"shares":2659,"price":164.7601,"value":438097.1059,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $164.5201 to $165.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45732,"source":{"system":"sec-edgar","filing":"0001144204-16-125866","document":"v449570_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420416125866/v449570_4.xml","form_type":"4"}}]}